Riskpilot← Back to searchSign inGet full accessChandan Läkartjänst AB
ABActiveOrg 5590868617Gökegårdsvägen 11General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2025
SEK 640K
EBITDA margin
82.0%
+933% vs 2024
Equity ratio
65.7%
Financial strength
Net profit 2025
SEK 425K
+808% vs 2024
| Revenue | SEK 640K | — |
| EBITDA | SEK 525K | +933% |
| Net profit | SEK 425K | +808% |
| Total assets | SEK 759K | +239% |
| Equity | SEK 499K | +565% |
| Employees | 1 | — |
Legal name
Chandan Läkartjänst AB
Org number
5590868617
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 november 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska sälja läkarkompetens, bedriva vård och därmed förenlig verksamhet.
Address
Gökegårdsvägen 11
Email
dr.chandan88@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 743 | 0 | 640 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −22 | −18 | 658 | −63 | 525 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −22 | −18 | 658 | −63 | 525 |
| Net financials | −1 | — | — | 3 | −3 |
| Profit before tax | −22 | −18 | 658 | −60 | 522 |
| Tax | −0 | −1 | −130 | −0 | −97 |
| Net profit | −22 | −19 | 528 | −60 | 425 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 150 | 130 | 972 | 224 | 759 |
| Equity | 146 | 127 | 655 | 75 | 499 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 | 3 | 317 | 149 | 260 |
| Total debt | 4 | 3 | 317 | 149 | 260 |
EBITDA margin
82.0%
This company
15.8%
Market median
+419% vs market
20212025
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
20212025
Return on equity
85.2%
This company
18.4%
Market median
+363% vs market
20212025
Net profit margin
66.4%
This company
8.1%
Market median
+720% vs market
20212025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
KS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2023 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Chandan Läkartjänst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kuldip Singh Chandan | Deputy Chief Executive Officer | 0 companies |
| Rasha Chandan | Deputy Chief Executive Officer | 0 companies |
| Amar Paul Singh Chandan | Chief Executive Officer | 0 companies |